SVB Leerink Downgrades Diplomat Pharmacy (DPLO) to Market Perform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- Wall St indexes fall to two-week lows as rising bond yields, disappointing Walmart results drag
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Deutsche Bank calls Treasury buyback doubling similar to ’operation twist’
Diplomat Pharmacy (DPLO) PT Lowered to $8 at Mizuho Securities
February 25, 2019 7:12 AM ESTMizuho Securities analyst Ann Hynes lowered the price target on Diplomat Pharmacy (NYSE: DPLO) to $8.00 (from $14.00) while maintaining a Neutral rating. DPLO withdrew previously issued 2019 guidance, delayed its earnings report (to March 15) and announced its intention to take an impairment charge on the... More
